Latest news
Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 00:10:39 GMTThe Small Cap Watch: Healthcare, critical minerals and gold explorers advance projects - Proactive financial newsProactive financial news · Wed, 05 Aug 2026 23:56:38 GMTActinogen to Host Alzheimer’s Treatment Forum as Xanamem Program Advances - TipRanksTipRanks · Wed, 05 Aug 2026 03:05:21 GMTActinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI - Proactive InvestorsProactive Investors · Sat, 01 Aug 2026 00:00:00 GMTActinogen Medical (ASX:ACW) Gains Momentum as Alzheimer’s Trial Progress and Regulatory Milestones Lift Investor Confidence - KalkineKalkine · Thu, 30 Jul 2026 07:00:00 GMT